Clinical trial · Observational
Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.
Analysis of the Cost of Using FLUOrescence in Green of Indocyanine for the Detection of the Sentinel Lymph Node in the Breast Cancer.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to analyze the average direct costs of each of these techniques, represented by the costs directly linked to the management of breast cancer, to the surgical intervention and to the techniques evaluated (Indocyanine Green and isotopes) which are: consultations, hospitalizations, resources consumed during the surgical intervention, as well as the time of the patients, transport...
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sentinel Lymph Node | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sentinel node detection technique | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patient eligible for the sentinel lymph node technique by lndocyanine Green.
- description
- To evaluate the overall cost at 1 month of the sentinel lymph node detection technique using Indocyanine Green in patients with breast cancer, from the point of view of the health insurance and the hospital.
- interventionNames
- Other: Sentinel node detection technique
- label
- Patient eligible for the sentinel lymph node technique by isotopes.
- description
- To evaluate the overall cost at 1 month of the sentinel lymph node detection technique using isotopes in patients with breast cancer, from the point of view of health insurance and the hospital.
- interventionNames
- Other: Sentinel node detection technique
Primary outcomes (1)
- measure
- Average direct costs of the two techniques assessed (Indocyanine Green and isotopes)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient aged 18 or over, having given her oral non-objection ; * Patient with histologically proven breast cancer ; * Patient eligible for the sentinel lymph node technique by Indocyanine Green or isotopes. Exclusion Criteria: * Patient who has expressed her opposition to the use of her medical data ; * Patient under legal protection, guardianship or curatorship ; * Pregnant patient ; * Patient not affiliated to a social security scheme.
References
Publications (0)
Data not yet available